Investment House LLC boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 85.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 91,965 shares of the exchange traded fund’s stock after buying an additional 42,450 shares during the period. Investment House LLC owned 0.15% of SPDR S&P Biotech ETF worth $9,215,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. DHJJ Financial Advisors Ltd. purchased a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth approximately $25,000. Capital A Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $26,000. Johnson Financial Group Inc. acquired a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth $31,000. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth $32,000. Finally, Davis Capital Management acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $35,000.
SPDR S&P Biotech ETF Trading Down 2.7%
NYSEARCA:XBI opened at $128.04 on Friday. The company has a market cap of $8.52 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $132.09. The company’s 50-day moving average price is $122.60 and its 200-day moving average price is $105.88.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Your Signature Is Missing – Act Before It’s Too Late
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
